whats the difference between tirzepatide and semaglutide key differences, weight loss results (2026) Tirzepatide vs. Semaglutide: Which is

Phase 3 data from the TRIUMPH-4 study, released in December of last year, showed 28.7% average body weight loss at the 12 mg dose over 68 weeks

Their main sites of action are white and brown adipose tissue, and muscle

This matters because lean soft tissue loss comprised 26% to 40% of weight loss in recent trials of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists

Multi-agonist mechanisms and outcomes have attracted strong and growing attention

RYBELSUS may cause serious side effects, including: inflammation of your pancreas (pancreatitis)

Este texto foi escrito pela Dra Luciana Sampaio Pres (@endocrinoluperes) em colaborao com o mdico proctologista Dr